Form 4: Guardant Health's Chief Medical Officer Craig Eagle Reports Stock Transactions
SEC Form 4 Filing
Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting and disposal of restricted stock units to cover tax obligations.
Summary
- On January 1, 2025, Craig Eagle, the Chief Medical Officer of Guardant Health, engaged in transactions involving common stock and restricted stock units.
- He acquired 1,714 and 1,667 shares of common stock through the vesting of restricted stock units.
- 1,387 shares were disposed of to cover tax withholding obligations at a price of $30.55 per share.
- Following these transactions, Eagle directly owns 25,956 shares of common stock and holds 11,999 and 11,671 restricted stock units.
- The restricted stock units vest over three and four-year periods with quarterly installments.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It reflects standard compensation practices involving stock-based awards.
Comparison to Industry Standards
- Stock-based compensation, including restricted stock units, is a common practice among publicly traded companies, particularly in the technology and healthcare sectors, to align the interests of executives with those of shareholders.
- Companies like Roche and Illumina also utilize stock-based compensation for their executives.
- The vesting schedules described are typical, with vesting occurring over several years to incentivize long-term commitment.
Stakeholder Impact
- The transactions have a minimal direct impact on shareholders, as they involve the vesting of previously granted stock awards and the sale of a small portion of shares to cover tax obligations.
- The transactions do not significantly alter the ownership structure of the company.
Key Dates
| Date | Description |
|---|---|
| November 7, 2022 | Date of restricted stock unit award that vests over a four-year period. |
| December 13, 2023 | Date of restricted stock unit award that vests over a three-year period. |
| October 1, 2023 | 25% of the shares subject to the November 7, 2022 award vested. |
| October 1, 2024 | 33% of the shares subject to the December 13, 2023 award vested. |
| January 1, 2025 | Date of reported transactions: vesting of restricted stock units and disposal of shares for tax obligations. |
| January 3, 2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.